Related Experiment Video
Updated: Mar 11, 2026

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
Biofilm inhibitors targeting the outer membrane protein A of Pasteurella multocida in swine
Anchanee Kubera1,2, Arinthip Thamchaipenet1,2, Menachem Shoham3
1a Department of Genetics , Faculty of Science, Kasetsart University , Bangkok , Thailand.
Abstract:
Pasteurella multocida (Pm) is the causative agent of atrophic rhinitis in swine. This study aimed to discover biofilm inhibitors against swine Pm to counteract antibiotic resistance and decrease virulence. The virulence factor outer membrane protein A (OmpA) was targeted. A library of drugs approved by the Food and Drug Administration (FDA) was used to perform virtual screening against PmOmpA. The top-scoring compounds had no effect on the growth of Pm serotype A or D. Mycophenolate mofetil showed the highest efficacy in inhibiting biofilm formation by Pm serotype A, with an IC50 of 7.3 nM. For Pm serotype D, indocyanine green showed the highest effect at an IC50 of 11.7 nM. Nevertheless, these compounds had no effect on an established biofilm of Pm. This study offers an alternative way to prevent biofilm formation by Pm that could also be applied to other pathogens.
Insights
This study identified FDA-approved drugs to inhibit biofilm formation in swine Pasteurella multocida (Pm). Mycophenolate mofetil and indocyanine green showed efficacy, offering alternatives to antibiotics for controlling Pm virulence.
Area of Science:
- Veterinary Microbiology
- Bacterial Pathogenesis
- Drug Discovery
Background:
- Pasteurella multocida (Pm) causes atrophic rhinitis in swine, leading to significant economic losses.
- Antibiotic resistance and virulence of Pm necessitate alternative control strategies.
- Biofilm formation by Pm contributes to its persistence and resistance.
Purpose of the Study:
- To discover novel biofilm inhibitors against swine Pm.
- To target the outer membrane protein A (OmpA) virulence factor.
- To identify compounds that counteract antibiotic resistance and reduce Pm virulence.
Main Methods:
- Virtual screening of FDA-approved drugs against the PmOmpA protein.
- Assessing the efficacy of top-scoring compounds on Pm biofilm formation.
- Determining IC50 values for selected inhibitors against Pm serotypes A and D.
Main Results:
- Mycophenolate mofetil inhibited Pm serotype A biofilm formation (IC50 = 7.3 nM).
- Indocyanine green inhibited Pm serotype D biofilm formation (IC50 = 11.7 nM).
- Identified compounds did not affect bacterial growth or established biofilms.
Conclusions:
- FDA-approved drugs can inhibit Pm biofilm formation, offering a potential alternative to antibiotics.
- Targeting OmpA is a viable strategy for discovering biofilm inhibitors.
- These findings could be extended to control other bacterial pathogens.
More Related Videos
10:17Methodologies for Studying B. subtilis Biofilms as a Model for Characterizing Small Molecule Biofilm Inhibitors
Published on: October 9, 2016
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Biofilms
Biological Methods for Microbial Control